Literature DB >> 8314794

Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant.

P Masson1, S Adkins, P Gouet, O Lockridge.   

Abstract

Kinetics of recombinant fluoride-2 variant of human butyrylcholinesterase (Gly390 Val) secreted by Chinese hamster ovary cells were compared to recombinant usual and to usual butyrylcholinesterase purified from human plasma. The usual and fluoride-2 variant were indistinguishable with regard to hydrolysis of benzoylcholine (Km = 5 microM), neutral esters, and at high concentrations of acetylthiocholine, propionylthiocholine, and butyrylthiocholine. However, at low substrate concentrations Km values for acetylthiocholine and succinyldithiocholine were 2-6-fold higher for the fluoride-2 variant. pH rate profiles revealed small differences in pKa that could be attributed to changes in the active site histidine environment. On the other hand, Arrhenius plot analysis of o-nitrophenylbutyrate hydrolysis at pH 7.5 showed no difference in activation energy between fluoride-2 and usual butyrylcholinesterases. Both exhibited an anomalous temperature dependence with a wavelike change in activation energy around 18 degrees C. Affinity of the fluoride-2 variant for sodium fluoride, tacrine, dibucaine, amodiaquin, and succinyldicholine was lower than for usual enzyme. Apparent Ki for succinyldicholine was 125 microM for the fluoride-2 variant and 20 microM for the usual enzyme. Organophosphate inhibition showed equivalent reactivity, indicating that the point mutation altered only the binding properties of the variant. Thus, Km and Ki changes explain the succinyldicholine sensitivity of people carrying the fluoride-2 variant.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314794

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.

Authors:  P Masson; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Effects of soman inhibition and of structural differences on cholinesterase molecular dynamics: a neutron scattering study.

Authors:  F Gabel; M Weik; P Masson; F Renault; D Fournier; L Brochier; B P Doctor; A Saxena; I Silman; G Zaccai
Journal:  Biophys J       Date:  2005-08-12       Impact factor: 4.033

3.  Unexpected acetylcholinesterase activity of cocaine esterases.

Authors:  Claude J Rogers; Lisa M Eubanks; Tobin J Dickerson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2006-12-06       Impact factor: 15.419

4.  Two invertebrate acetylcholinesterases show activation followed by inhibition with substrate concentration.

Authors:  V Marcel; L G Palacios; C Pertuy; P Masson; D Fournier
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

5.  Endogenous butyrylcholinesterase in SV40 transformed cell lines: COS-1, COS-7, MRC-5 SV40, and WI-38 VA13.

Authors:  M Kris; O Jbilo; C F Bartels; P Masson; S Rhode; O Lockridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

6.  Bacterial Expression of Human Butyrylcholinesterase as a Tool for Nerve Agent Bioscavengers Development.

Authors:  Xavier Brazzolotto; Alexandre Igert; Virginia Guillon; Gianluca Santoni; Florian Nachon
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.